A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status:
Completed
Trial end date:
2018-02-23
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, parallel group, multicenter clinical study to evaluate
the efficacy, safety, pharmacokinetics and immunogenicity of LBAL compared to Humira® in
subjects with active Rheumatoid Arthritis despite Methotrexate therapy.